← All stocks

Climb Bio, Inc.

CLYM Net buying
CIK 0001768446 #2557 in the set updated 19 Sep 2026
Bought (120 mo)
$100.73M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$6.15M
$2.69M on a plan · $0.00 straight out of an exercise
Sold at will
$3.46M
15 of 27 sales
Net
+$94.58M
+$97.28M against sales at will

By person

6 insiders · 41 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$90.73M (7)
+$90.73M
4,244,516
7.39%
$58.01M
AI ETI LLC entity
10% owner
$10.00M (1)
+$10.00M
5,009,400
8.72%
$68.47M
Morisset Valerie
EVP, R&D AND CSO
$3.45M (14)
−$3.45M
31,317
0.0545%
$428.05K
−79.2%
Thomas Stephen Basil
Director
$2.25M (5) scheduled
−$2.25M
467,969
0.8148%
$6.40M
+13.2%
Brennan Aoife
President and CEO
$432.13K (2) scheduled
−$432.13K
87,731
0.1527%
$1.20M
+4,910%
Pimblett Emily
SVP, Finance & CAO
$24.33K (6) scheduled
−$24.33K
18,888
0.0329%
$258.16K
Insider
Date
Role
Action
Shares
Price
Amount
RA CAPITAL MANAGEMENT, L.P.
5 Jan 2026
Director
Buy indirect
7,111
$3.50
$24.89K
RA CAPITAL MANAGEMENT, L.P.
12 Dec 2025
Director
Buy indirect
101,462
$2.86
$290.18K
RA CAPITAL MANAGEMENT, L.P.
11 Dec 2025
Director
Buy indirect
213,099
$2.18
$464.56K
RA CAPITAL MANAGEMENT, L.P.
27 Jun 2024
Director
Buy indirect
1,059,375
$3.84
$4.07M
RA CAPITAL MANAGEMENT, L.P.
27 Jun 2024
Director
Buy indirect
11,949,171
$3.84
$45.88M
AI ETI LLC
12 Aug 2021
10% owner
Buy
800,000
$12.50
$10.00M
RA CAPITAL MANAGEMENT, L.P.
12 Aug 2021
Director
Buy indirect
195,218
$12.50
$2.44M
RA CAPITAL MANAGEMENT, L.P.
12 Aug 2021
Director
Buy indirect
3,004,782
$12.50
$37.56M

What was left out

Form 4 filings counted 95
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 0
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 37,606,580
History held since 11 Aug 2021